Story perspectives
Stanford's Breakthrough Antibody Treatment Eliminates Chemo for Kids
8/24/2025
37 3
1 of 1
Story summary
- A Phase 1 clinical trial at Stanford Medicine tested an antibody treatment for children with Fanconi anemia, eliminating the need for toxic chemotherapy and radiation.
- Results indicated nearly 100% donor cell chimerism in patients after two years.
- Researchers plan to extend this method to other genetic conditions and enhance transplant safety.
